ARCHIVES

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Eight applications Received For NSABP chairman

September 9, 1994

NCI Pilot to Speed Phase III Trials Deemed Unsuccessful, Will Be Shut Down

November 22, 2002

Nexavar Improves PFS In HER-2 Negative Breast Cancer

May 27, 2011

Clinical Education Grants Held To 170 Payline, No New Awards; Organ Site Renewals Limited To 180

March 26, 1982

Perifosine, Sorafenib Combination Well Tolerated in Several Lymphomas

December 28, 2012

In Brief: White House Conservative Said Seeking Ouster Of Schweiker; Potter urges Greater Commitment

November 26, 1982